TG Therapeutics, created in 1993 (United States), from 2214 competing brands. The TG Therapeutics brand is owned by TG Therapeutics, a company listed in New York. TG Therapeutics is part of the Biotechnology activity sector.

TG Therapeutics is a brand of TG Therapeutics (TGTX) Share price

Share price and profitability of the share TG Therapeutics (TG Therapeutics)

Buy TG Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 13.91

Portfolio valuation
TG Therapeutics over 5 years* USD 24.42

Stock market history TG Therapeutics

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more